Sarah Briggs
BMBCh MA DPhil MRCP
NIHR Clinical Lecturer
Sarah is an NIHR funded Clinical Lecturer in the CELS group at the Centre for Human Genetics, and a Junior Research Fellow at the Centre for Personalised Medicine and St Anne's College. She is an Honorary Specialty Registrar in Medical Oncology at Oxford University Hospitals NHS Foundation Trust. Sarah's research focuses on sustainable healthcare.
Sarah studied Medicine at New College, Oxford, and subsequently worked as an Academic Foundation Doctor at King's College Hospital, London. She returned to Oxford as an Academic Clinical Fellow in Medical Oncology, where she worked with Professor Ian Tomlinson on studies of POLE and POLD1 genes in familial and sporadic cancers. She subsequently completed her MRC-funded DPhil under the supervision of Prof Tomlinson and Prof Sarah Wordsworth, developing polygenic risk scores for bowel cancer and evaluating their potential use in the Bowel Cancer Screening Programme.
During her DPhil Sarah became increasingly concerned by the impact of the climate crisis on health, and of the contribution of healthcare and health research to growing carbon emissions and environmental damage. Her Lectureship research explores a number of issues in this area. She is particularly interested in public and patient understanding and views around the relationship between environment, health, and healthcare, and in efforts to reduce the environmental impact of Oncology and Genomic Medicine and research.
Recent publications
-
Building climate resilient and low carbon health systems.
Journal article
Briggs S., (2023), BMJ (Clinical research ed.), 383
-
Author Correction: Deciphering colorectal cancer genetics through multi-omic analysis of 100,204 cases and 154,587 controls of European and east Asian ancestries.
Journal article
Fernandez-Rozadilla C. et al, (2023), Nature genetics, 55, 519 - 520
-
A novel genetic marker of fluoropyrimidine-induced cardiovascular toxicity
Conference paper
Palles C. et al, (2023), JOURNAL OF CLINICAL ONCOLOGY, 41
-
Deciphering colorectal cancer genetics through multi-omic analysis of 100,204 cases and 154,587 controls of European and east Asian ancestries.
Journal article
Fernandez-Rozadilla C. et al, (2023), Nature genetics, 55, 89 - 99
-
Integrating genome-wide polygenic risk scores and non-genetic risk to predict colorectal cancer diagnosis using UK Biobank data: population based cohort study.
Journal article
Briggs SEW. et al, (2022), BMJ (Clinical research ed.), 379